AnaptysBio, Inc. (ANAB) Earnings
NASDAQ·Healthcare·Biotechnology
$66.06
-0.68%
Mkt Cap $1.49B
Next Earnings
In 5 daysMon, May 4, 2026
EPS Estimate
-$0.67
7 analysts
Revenue Estimate
$23.73M
Last quarter: beat by +77.53% on EPS, +24.37% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.49B
P/E
—
Fwd P/E
—
P/S
6.35
Rev TTM
—
EPS TTM
-$0.52